Amgen’s expertise
nearly four decades of experience designing and developing innovative biologics

KANJINTI^® has been developed with the same rigour, with the same group of scientists and in the same manufacturing facilities as Amgen’s innovative biologics to ensure high quality.

Amgen has been at the forefront of biologic innovation, particularly in oncology, and has served millions of cancer patients over the years. The reliability of Amgen’s manufacturing and supply provides confidence that its biologics are consistently delivered to serve every patient, every time.